TABLE 2.
Clinical endpoint | Performance indicatora | HCII (%) | HCII with reanalysis (%) | PCR (%) | PCR with reanalysis (%) |
---|---|---|---|---|---|
Histopathology, CIN II+ | Sensitivity | 91.8 | 90.8 | 92.9 | 92.9 |
Specificity | 24.1 | 30.4 | 30.4 | 27.8 | |
PPV | 60.0 | 61.8 | 62.3 | 61.5 | |
NPV | 70.4 | 72.7 | 77.4 | 75.9 | |
Histopathology, CIN III | Sensitivity | 95.6 | 95.6 | 100.0 | 100.0 |
Specificity | 18.9 | 23.5 | 23.5 | 22.7 | |
PPV | 28.7 | 29.9 | 30.8 | 30.6 | |
NPV | 92.6 | 93.9 | 100.0 | 100.0 | |
Cytology, CIN II+ | Sensitivity | 80.0 | 80.0 | 80.0 | 80.0 |
Specificity | 85.4 | 85.4 | 83.5 | 83.5 | |
PPV | 21.1 | 21.1 | 19.0 | 19.0 | |
NPV | 99.0 | 99.0 | 99.1 | 99.0 | |
Cytology, CIN III | Sensitivity | 100.0 | 100.0 | 100.0 | 100.0 |
Specificity | 84.0 | 84.0 | 82.1 | 82.1 | |
PPV | 10.5 | 10.5 | 9.5 | 9.5 | |
NPV | 100.0 | 100.0 | 100.0 | 100.0 |
PPV, positive predictive values; NPV, negative predictive values.